Status:
COMPLETED
Hypofractionated Radiotherapy as Primary Therapy for Prostate Cancer
Lead Sponsor:
University Hospital, Ghent
Conditions:
Prostate Cancer
Eligibility:
MALE
40-80 years
Phase:
PHASE2
Brief Summary
External beam radiotherapy (RT) is one of the standard curative treatment options for patients with prostate cancer (PC). Several randomised trials have shown excellent long-term biochemical outcome w...
Eligibility Criteria
Inclusion
- patients with T1-4 N0 M0 prostate cancer
Exclusion
- other no skin cancer diagnosed within 5 years prior to enrolment
- no informed consent
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 14 2020
Estimated Enrollment :
346 Patients enrolled
Trial Details
Trial ID
NCT01921803
Start Date
August 1 2013
End Date
July 14 2020
Last Update
December 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ghent University Hospital
Ghent, Belgium, 9000